Covenant Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,598
Closed -$1.17M 121
2025
Q4
$1.17M Hold
4,598
0.34% 34
2025
Q3
$1.14M Hold
4,598
0.32% 37
2025
Q2
$1.1M Hold
4,598
0.33% 34
2025
Q1
$1.04M Sell
4,598
-401
-8% -$88.2K 0.34% 36
2024
Q4
$1.03M Sell
4,999
-42
-0.8% -$9.21K 0.32% 38
2024
Q3
$1.22M Buy
5,041
+42
+0.8% +$9.82K 0.36% 38
2024
Q2
$1.1M Hold
4,999
0.33% 41
2024
Q1
$1.12M Hold
4,999
0.33% 39
2023
Q4
$1.1M Hold
4,999
0.35% 40
2023
Q3
$1.1M Buy
+4,999
New +$1.13M 0.4% 35
2019
Q1
Sell
-4,700
Closed -$502K 192
2018
Q4
$502K Buy
+4,700
New +$525K 0.24% 31

Other funds holding STE

Covenant Partners's STE Position: Q1 2026 in Review

Covenant Partners sold out of Steris (STE) in Q1 2026, closing a stake of 4,598 shares — an estimated $1.17M sold.

Covenant Partners first reported a position in STE in Q4 2018 and held it in 11 quarters. The position peaked at $1.22M in Q3 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Covenant Partners reported no remaining Steris position as of Q1 2026 after selling out during the quarter.
  • Covenant Partners sold 4,598 Steris shares in Q1 2026, an estimated $1.17M.
  • Covenant Partners first reported a position in Steris in Q4 2018 and held it in 11 quarters.
  • Covenant Partners's Steris position peaked at $1.22M in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Covenant Partners's 13F filing for Q1 2026.